To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Has Bill McGlashan poisoned the impact well?
Don’t be surprised if TPG goes on to successfully raise the second Rise Fund; the actions of its erstwhile boss, however, may make it harder for other impact investors.
